Oct 15 2013
The C-RAD GEMini detector system has been especially designed for VMAT treatments in advanced radiation therapy. The detector will be used both as an imaging and dosimetry device.
C-RAD Imaging has during 2013 focused the development on optimizing the image quality of the GEMini detector. As a result resolution and contrast have been taken to a new level. Clinical images were acquired in Salzburg, confirming these improvements. Some remaining scatter effects in the image have led to an additional hardware modification.
A pre-clinical test showed now the successful reduction of internal scatter and therewith an improved image sharpness. The technology used in the test setup will be adapted to the clinical version of the GEMini detector. New tests under clinical conditions will then be performed in Salzburg.
The design is based on a technology, which is developed at C-RAD. The patent application for the US has been submitted for this innovation in September.
Tim Thurn, CEO, C-RAD AB:
“After the successful result, we are starting confident in the next round of testing together with our partners in Salzburg. We are convinced the new detector, as the only detector on the market, will fulfill the high demands for use in imaging as well as for online dosimetry in advanced radiation therapy.”